Achieve Life Sciences Inc (SP4P) — Financial Flexibility Index
Achieve Life Sciences Inc (SP4P) has a Financial Flexibility Index of -0.89x as of December 2025. Free cash flow of €-17.98 Million (operating CF €-17.98 Million minus capex €0.00) represents -1% of total liabilities (€20.27 Million). Also explore Achieve Life Sciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Achieve Life Sciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Achieve Life Sciences Inc across 10 annual periods. Check asset allocation strategy of Achieve Life Sciences Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Achieve Life Sciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Achieve Life Sciences Inc. For the full company profile including market capitalisation, see Achieve Life Sciences Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | €-49.46 Million | €-49.47 Million | €20.27 Million | ▼ -45.3% |
| 2024 | -1.68x | €-29.77 Million | €-29.77 Million | €17.73 Million | ▼ -42.9% |
| 2023 | -1.17x | €-24.46 Million | €-24.48 Million | €20.82 Million | ▲ +32.2% |
| 2022 | -1.73x | €-37.55 Million | €-37.55 Million | €21.67 Million | ▼ -14.6% |
| 2021 | -1.51x | €-29.44 Million | €-29.44 Million | €19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | €-13.46 Million | €-13.47 Million | €3.01 Million | ▲ +10.8% |
| 2019 | -5.01x | €-15.16 Million | €-15.22 Million | €3.03 Million | ▼ -55.4% |
| 2018 | -3.22x | €-10.58 Million | €-10.62 Million | €3.28 Million | ▲ +28.4% |
| 2017 | -4.50x | €-9.06 Million | €-9.11 Million | €2.01 Million | ▼ -24437.5% |
| 2016 | -0.02x | €-156.00K | €-202.00K | €8.50 Million | — |